title: Identification of disulfide-linked apolipoprotein species in human lipoproteins.
abstract: We wished to determine whether apolipoprotein C-IIToronto, a mutant form of apolipoprotein C-II that contains a C-terminal cysteine residue, exists as a monomeric species or as multiple disulfide-linked species in plasma lipoproteins. The plasma lipoproteins from a heterozygous carrier and two homozygous carriers of apoC-IIToronto were investigated. The mutant apolipoprotein was found in homodimeric form and as heterodimers with apolipoprotein A-II, apolipoprotein B-100, and apolipoprotein E. Of particular interest was the demonstration of the existence of the disulfide-linked species apolipoprotein B-100:A-II and B-100:C-IIToronto in the very low density and low density lipoproteins in subjects who were carriers of apoC-IIToronto. We also observed that apoE3:C-IIToronto and apoE3:A-II dimers were present in the chylomicrons and very low density lipoproteins of these subjects. The observation of the existence of apolipoprotein B-100:A-II was extended to other hypercholesterolemic and hypertriglyceridemic subjects. The highest proportion of apolipoprotein B-100:A-II was observed in the very low density lipoproteins of hypertriglyceridemic subjects. The concentration of this species was significantly higher in hyperlipidemic subjects than in normolipidemic controls. These results demonstrate that the molecular species of cysteine-containing apolipoproteins are complex and should be considered in studies of human lipoprotein composition and function.
authors.affiliation: Department of Biochemistry, University of Toronto, Ontario, Canada.
authors.forename: P W
authors.initials: PW
authors.lastname: Connelly
authors.forename: G F
authors.initials: GF
authors.lastname: Maguire
authors.forename: C
authors.initials: C
authors.lastname: Vezina
authors.forename: R A
authors.initials: RA
authors.lastname: Hegele
authors.forename: J A
authors.initials: JA
authors.lastname: Little
mesh_terms: D016633:Apolipoprotein A-II / Q000378:metabolism; D053299:Apolipoprotein B-100; D053304:Apolipoprotein C-II; D001053:Apolipoproteins / Q000378:metabolism*; D001055:Apolipoproteins B / Q000378:metabolism; D001056:Apolipoproteins C / Q000737:chemistry / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism*; D002914:Chylomicrons / Q000097:blood; D004220:Disulfides / Q000097:blood*; D005260:Female; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood; D007118:Immunoassay; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D046911:Macromolecular Substances; D008297:Male
chemical_list: D016633:Apolipoprotein A-II; D053299:Apolipoprotein B-100; D053304:Apolipoprotein C-II; D001053:Apolipoproteins; D001055:Apolipoproteins B; D001056:Apolipoproteins C; D002914:Chylomicrons; D004220:Disulfides; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D046911:Macromolecular Substances; C050929:apolipoprotein C-II (Toronto)